Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
•WHO recommends countries monitor the safety profile of new drugs and regimens.•WHO developed the active TB drug safety monitoring and management (aDSM) package.•aDSM data are not yet available globally.•A project to prove aDSM feasibility was launched by the Global Tuberculosis Network; 41 centres...
Saved in:
| Published in: | International Journal of Infectious Diseases Vol. 83; pp. 72 - 76 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Canada
Elsevier Ltd
01.06.2019
Elsevier BV Elsevier |
| Subjects: | |
| ISSN: | 1201-9712, 1878-3511, 1878-3511 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!